These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2721208)

  • 41. CDP571, a humanized antibody to human tumor necrosis factor-alpha: safety, pharmacokinetics, immune response, and influence of the antibody on cytokine concentrations in patients with septic shock. CPD571 Sepsis Study Group.
    Dhainaut JF; Vincent JL; Richard C; Lejeune P; Martin C; Fierobe L; Stephens S; Ney UM; Sopwith M
    Crit Care Med; 1995 Sep; 23(9):1461-9. PubMed ID: 7664546
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.
    Abraham E; Wunderink R; Silverman H; Perl TM; Nasraway S; Levy H; Bone R; Wenzel RP; Balk R; Allred R
    JAMA; 1995 Mar 22-29; 273(12):934-41. PubMed ID: 7884952
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Soluble CD14 (sCD14) levels in patients with multiple organ failure (MOF).
    Endo S; Inada K; Kasai T; Takakuwa T; Nakae H; Kikuchi M; Yamashita H; Yoshida M
    Res Commun Chem Pathol Pharmacol; 1994 Apr; 84(1):17-25. PubMed ID: 7518965
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Respiratory burst capability of polymorphonuclear neutrophils and TNF-alpha serum levels in relationship to the development of septic syndrome in critically ill patients.
    Trautinger F; Hammerle AF; Pöschl G; Micksche M
    J Leukoc Biol; 1991 May; 49(5):449-54. PubMed ID: 1849953
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of inflammatory cytokine concentration and physiologic parameters in septic shock.
    Liaw YS; Yu CJ; Wu HD; Yang PC
    J Formos Med Assoc; 1997 Sep; 96(9):685-90. PubMed ID: 9308320
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor necrosis factor gene polymorphism results in high TNF level in sepsis and septic shock.
    Kothari N; Bogra J; Abbas H; Kohli M; Malik A; Kothari D; Srivastava S; Singh PK
    Cytokine; 2013 Feb; 61(2):676-81. PubMed ID: 23317877
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Calandra T; Baumgartner JD; Glauser MP
    Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Perioperative TNF alpha and IL-6 concentrations correlate with septic state, organ function, and APACHE II scores in intra-abdominal infection.
    Függer R; Zadrobilek E; Götzinger P; Klimann S; Rogy M; Winkler S; Andel H; Mittelböck M; Roth E; Schulz F
    Eur J Surg; 1993 Oct; 159(10):525-9. PubMed ID: 8286509
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute-phase proteins during the treatment of severe sepsis in humans.
    Dofferhoff AS; Bom VJ; de Vries-Hospers HG; van Ingen J; vd Meer J; Hazenberg BP; Mulder PO; Weits J
    Crit Care Med; 1992 Feb; 20(2):185-92. PubMed ID: 1371097
    [TBL] [Abstract][Full Text] [Related]  

  • 50. INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group.
    Cohen J; Carlet J
    Crit Care Med; 1996 Sep; 24(9):1431-40. PubMed ID: 8797612
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum tumor necrosis factor-alpha in neonatal sepsis.
    Atici A; Satar M; Cetíner S; Yaman A
    Am J Perinatol; 1997 Aug; 14(7):401-4. PubMed ID: 9263559
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in critical illness including sepsis and septic shock: relation to disease severity, multiple organ dysfunction, and mortality.
    Presneill JJ; Waring PM; Layton JE; Maher DW; Cebon J; Harley NS; Wilson JW; Cade JF
    Crit Care Med; 2000 Jul; 28(7):2344-54. PubMed ID: 10921563
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumor necrosis factor-alpha at presentation in 60 cases of spontaneous canine acute pancreatitis.
    Ruaux CG; Pennington HL; Worrall S; Atwell RB
    Vet Immunol Immunopathol; 1999 Dec; 72(3-4):369-76. PubMed ID: 10628678
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of active nitrogen molecules in progression of septic shock.
    Kothari N; Bogra J; Kohli M; Malik A; Kothari D; Srivastava S; Keshari RS; Singh V; Barthwal MK; Dikshit M
    Acta Anaesthesiol Scand; 2012 Mar; 56(3):307-15. PubMed ID: 22192332
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma.
    Martin C; Boisson C; Haccoun M; Thomachot L; Mege JL
    Crit Care Med; 1997 Nov; 25(11):1813-9. PubMed ID: 9366763
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum tumor necrosis factor alpha and C-reactive protein in pediatric patients with sepsis and its correlation with microbiologic findings.
    Kumar S; Rizvi M
    Indian J Pathol Microbiol; 2010; 53(3):494-7. PubMed ID: 20699510
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans.
    Damas P; Reuter A; Gysen P; Demonty J; Lamy M; Franchimont P
    Crit Care Med; 1989 Oct; 17(10):975-8. PubMed ID: 2791581
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma levels of tumor necrosis factor in the adult respiratory distress syndrome.
    Roten R; Markert M; Feihl F; Schaller MD; Tagan MC; Perret C
    Am Rev Respir Dis; 1991 Mar; 143(3):590-2. PubMed ID: 2001071
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ceramide concentrations in septic patients: a possible marker of multiple organ dysfunction syndrome.
    Delogu G; Famularo G; Amati F; Signore L; Antonucci A; Trinchieri V; Di Marzio L; Cifone MG
    Crit Care Med; 1999 Nov; 27(11):2413-7. PubMed ID: 10579257
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasma cytokine determinations in emergency department patients as a predictor of bacteremia and infectious disease severity.
    Moscovitz H; Shofer F; Mignott H; Behrman A; Kilpatrick L
    Crit Care Med; 1994 Jul; 22(7):1102-7. PubMed ID: 8026198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.